- Home
- CBRE vs ALC Comparison
CBRE vs ALC Comparison
Compare CBRE & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBRE
- ALC
- Stock Information
- Founded
- CBRE 1906
- ALC 1945
- Country
- CBRE United States
- ALC Switzerland
- Employees
- CBRE N/A
- ALC N/A
- Industry
- CBRE Real Estate
- ALC Ophthalmic Goods
- Sector
- CBRE Finance
- ALC Health Care
- Exchange
- CBRE Nasdaq
- ALC Nasdaq
- Market Cap
- CBRE 36.9B
- ALC 43.0B
- IPO Year
- CBRE 2004
- ALC N/A
- Fundamental
- Price
- CBRE $133.69
- ALC $85.42
- Analyst Decision
- CBRE Buy
- ALC Buy
- Analyst Count
- CBRE 9
- ALC 10
- Target Price
- CBRE $150.33
- ALC $107.00
- AVG Volume (30 Days)
- CBRE 1.7M
- ALC 1.6M
- Earning Date
- CBRE 07-29-2025
- ALC 08-19-2025
- Dividend Yield
- CBRE N/A
- ALC 0.39%
- EPS Growth
- CBRE 2.39
- ALC 6.66
- EPS
- CBRE 3.28
- ALC 2.25
- Revenue
- CBRE $36,742,000,000.00
- ALC $9,925,000,000.00
- Revenue This Year
- CBRE $14.26
- ALC $6.22
- Revenue Next Year
- CBRE $9.02
- ALC $7.16
- P/E Ratio
- CBRE $40.77
- ALC $37.41
- Revenue Growth
- CBRE 13.15
- ALC 3.80
- 52 Week Low
- CBRE $85.74
- ALC $80.48
- 52 Week High
- CBRE $147.75
- ALC $101.10
- Technical
- Relative Strength Index (RSI)
- CBRE 62.93
- ALC 40.40
- Support Level
- CBRE $131.59
- ALC $84.49
- Resistance Level
- CBRE $135.87
- ALC $89.76
- Average True Range (ATR)
- CBRE 2.52
- ALC 1.09
- MACD
- CBRE 0.54
- ALC -0.01
- Stochastic Oscillator
- CBRE 84.99
- ALC 22.91
About CBRE CBRE Group Inc
CBRE Group provides a wide range of real estate services to owners, occupants, and investors worldwide, including leasing, property and project management, and capital markets advisory. CBRE's investment management arm manages over $140 billion for clients across diverse public and private real estate strategies.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.